Galtec
PrivateLast Round
Seed
Dec 15, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Galtec is a biotechnology company that develops immunotherapies based on the modulation of galectins for the treatment of cancer, autoimmune diseases, and chronic inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galtec Comparables
Compare Galtec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valora Therapeutics Inc. | 85% | |
| GlycoTherapeutics | 80% | |
| Palleon Pharmaceuticals | 76% | |
Galtec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 15, 2023 |
Galtec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| White Lions | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 34% MoM.
- Jan 7, 2026
Monthly visitors increased 136% MoM, reaching 1.4K.
Galtec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Galtec's valuation, stock price, and market status.